LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovation in CNS Treatments Neurana Pharmaceuticals is actively developing novel therapies for central nervous system disorders, with its lead product tolperisone targeting muscle spasms. This focus on acute neuromuscular conditions presents opportunities to engage healthcare providers and clinics that specialize in pain management, neurology, and physical therapy.

Recent Clinical Challenges The company recently announced that its Phase 3 RESUME-1 trial did not meet primary or key secondary endpoints, indicating potential upcoming needs for support in post-trial commercialization efforts, educational outreach, or alternative therapeutic applications within the neuromuscular space.

Strong Investor Backing With a substantial $60 million Series A funding from reputable venture firms such as Sofinnova and New Leaf Venture Partners, Neurana is well-positioned for product development and market entry initiatives, offering avenues for strategic partnerships, licensing deals, or technology collaborations.

Market Expansion Opportunities Although tolperisone is marketed outside the US, there is potential to support regulatory approval and distribution strategies within the American healthcare system, appealing to pharmaceutical distributors, healthcare providers, and pain specialists looking for innovative muscle spasm treatments.

Tech Stack and Digital Presence Neurana utilizes several digital tools including Google Analytics and Wix, indicating an active online engagement strategy. This opens opportunities for digital marketing, educational content partnerships, and targeted outreach to biotech community stakeholders and healthcare professionals.

Neurana Pharmaceuticals Tech Stack

Neurana Pharmaceuticals uses 8 technology products and services including Google Analytics Enhanced eCommerce, Wix, Twemoji, and more. Explore Neurana Pharmaceuticals's tech stack below.

  • Google Analytics Enhanced eCommerce
    Analytics
  • Wix
    Content Management System
  • Twemoji
    Font Scripts
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PHP
    Programming Languages
  • reCAPTCHA
    Security

Media & News

Neurana Pharmaceuticals's Email Address Formats

Neurana Pharmaceuticals uses at least 1 format(s):
Neurana Pharmaceuticals Email FormatsExamplePercentage
FLast@neuranapharma.comJDoe@neuranapharma.com
50%
FLast@neuranapharma.comJDoe@neuranapharma.com
50%

Frequently Asked Questions

Where is Neurana Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconNeurana Pharmaceuticals's main headquarters is located at 3525 Del Mar Heights Rd Suite 609 San Diego, California 92130 US. The company has employees across 2 continents, including North AmericaAsia.

What is Neurana Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Neurana Pharmaceuticals's main corporate office by phone at
+1-858-756-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurana Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconNeurana Pharmaceuticals's official website is neuranapharma.com and has social profiles on LinkedIn.

What is Neurana Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconNeurana Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neurana Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of October 2022, Neurana Pharmaceuticals has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include Small Business Owner: A. A.Senior Vice President And Chief Financial Officer: K. S.Director Corporate Development: J. H.. Explore Neurana Pharmaceuticals's employee directory with LeadIQ.

What industry does Neurana Pharmaceuticals belong to?

Minus sign iconPlus sign iconNeurana Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Neurana Pharmaceuticals use?

Minus sign iconPlus sign iconNeurana Pharmaceuticals's tech stack includes Google Analytics Enhanced eCommerceWixTwemojiGoogle Fonts APIjQueryLodashPHPreCAPTCHA.

What is Neurana Pharmaceuticals's email format?

Minus sign iconPlus sign iconNeurana Pharmaceuticals's email format typically follows the pattern of FLast@neuranapharma.com. Find more Neurana Pharmaceuticals email formats with LeadIQ.

How much funding has Neurana Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of October 2022, Neurana Pharmaceuticals has raised $60M in funding. The last funding round occurred on May 08, 2018 for $60M.

When was Neurana Pharmaceuticals founded?

Minus sign iconPlus sign iconNeurana Pharmaceuticals was founded in 2013.
Neurana Pharmaceuticals

Neurana Pharmaceuticals

Biotechnology ResearchCalifornia, United States11-50 Employees

Neurana Pharmaceuticals is a privately held clinical stage San Diego based specialty pharmaceutical company developing a novel treatment for acute muscle spasms.  The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders. 

Neurana's first drug candidate is tolperisone, which has been shown to be an effective treatment for muscle spasms and spasticity and is commercialized in markets outside of the United States. Clinical studies and commercial usage have shown that tolperisone is safe and efficacious, and that the drug is non-sedating and non-addictive.

In May 2018, Neurana completed a $60M Series A financing led by Sofinnova Ventures and included participation from New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital and MagnaSci Ventures.

Section iconCompany Overview

Headquarters
3525 Del Mar Heights Rd Suite 609 San Diego, California 92130 US
Phone number
+1-858-756-****
Website
neuranapharma.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $60M

    Neurana Pharmaceuticals has raised a total of $60M of funding over 1 rounds. Their latest funding round was raised on May 08, 2018 in the amount of $60M.

  • $1M

    Neurana Pharmaceuticals's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $60M

    Neurana Pharmaceuticals has raised a total of $60M of funding over 1 rounds. Their latest funding round was raised on May 08, 2018 in the amount of $60M.

  • $1M

    Neurana Pharmaceuticals's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    A. A.
    Small Business Owner
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. S.
    Senior Vice President And Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. H.
    Director Corporate Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. B.
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.